The invention describes specific sialylated structures present on human stem cells and cell populations derived thereof. The invention is especially directed to methods to control the status of stem cells by changing sialylation and/or fucosylation levels of the cells. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered. The control methods are preferably mass spectrometric methods.
申请公布号
CA2712425(A1)
申请公布日期
2008.07.24
申请号
CA20082712425
申请日期
2008.01.18
申请人
GLYKOS FINLAND LTD;SUOMEN PUNAINEN RISTI VERIPALVELU
发明人
LAINE, JARMO;SATOMAA, TERO;NATUNEN, JARI;JAATINEN, TAINA;HEISKANEN, ANNAMARI;NYSTEDT, JOHANNA